SSPE - the continuing challenge: a study based on serological evidence from a teritary care centre in India
Manayani, D.J.; Abraham, M.; Gnanamuthu, C.; Solomon, T.; Alexander, M.; Sridharan, G.
Indian Journal of Medical Microbiology 20(1): 16-18
2002
ISSN/ISBN: 0255-0857 PMID: 17657017 Document Number: 547014
To assess the prevalence of subacute sclerosing panencephalitis (SSPE). In the period June 96 to December' 98 an analysis for measles virus (MV) antibody was carried out on 103 serum-CSF pairs received from patients clinically suspected of SSPE. Measles antibody was detected in an indirect immunofluorescent assay (IIF) test. Antibody to measles was detectable in 49 (48%) of the serum-CSF pairs tested, a diagnostic criterion for SSPE. Antibody titers ranged from 20 to 1280 in serum and neat to 32 in CSF. The serum: CSF ratio ranged from 5:1 to 80:1. Of the 49 patients diagnosed to have SSPE, 36 were males and 13 females, and the age of the patients at the time of diagnosis of SSPE ranged from 5 to 26 years. Ten of the SSPE patients gave a history of measles vaccination. Inadequate vaccine coverage and quality of vaccine used continue to have an impact on occurrence of SSPE.